|
2012 Journal Article Revision and validation of a medication assessment tool for chronic cancer pain managementSalmany, Sewar S., Koopmans, Sara M., Treish, Imad M., El Jaber, Rana, Telfah, Shorouq and Tuffaha, Haitham W. (2012). Revision and validation of a medication assessment tool for chronic cancer pain management. The American Journal of Hospice and Palliative Medicine, 29 (8), 640-646. doi: 10.1177/1049909111435812 |
|
2012 Journal Article Glucarpidase for the treatment of life-threatening methotrexate overdoseTuffaha, H. W. and Al Omar, S. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48 (11), 705-711. doi: 10.1358/dot.2012.48.11.1871575 |
|
2012 Journal Article Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer centerTuffaha, Haitham W and Koopmans, Sara M (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18 (2), 180-185. doi: 10.1177/1078155211416529 |
|
2012 Journal Article Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer centerTuffaha, Haitham W., Abdelhadi, Ola and Al Omar, Suha (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34 (1), 27-31. doi: 10.1007/s11096-011-9600-4 |
|
2012 Conference Publication THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTSTuffaha, H. W., Hussein, A. A., Sharma, S., Abu-Jazar, H., Al-Rawi, O. S., Saad, A. M., Al-Zaben, A., Hussein, N. and Abdel-Rahman, F. A. (2012). THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF +/- CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.130 |
|
2012 Conference Publication COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTSTuffaha, H. W., Hussein, A. A. and Abdel-Rahman, F. A. (2012). COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS. BMT Tandem Meeting, San Diego Ca, Feb 01-05, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.bbmt.2011.12.132 |
|
2012 Conference Publication Adverse drug reactions in bone marrow transplant patientsNajjar, R., Tuffaha, H., Abdel-Rahman, F., Hussein, A. and Jazar, H. A. (2012). Adverse drug reactions in bone marrow transplant patients. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Geneva, Switzerland, 1-4 April, 2012. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bmt.2012.37 |
|
2011 Journal Article Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicityTuffaha, Haitham W and Al Omar, Suha (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17 (2), 136-40. doi: 10.1177/1078155209348720 |
|
2010 Journal Article Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumorTuffaha, Haitham and Abdel-Rahman, Fawzi Abdel-Latif (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/ Oncology and Stem Cell Therapy, 3 (4), 203-205. doi: 10.5144/1658-3876.2010.203 |
|
2008 Journal Article The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient settingTuffaha, Haitham W., Treish, Imad M. and Zaru, Luna (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14 (3), 131-8. doi: 10.1177/1078155208091249 |
|
2005 Other Outputs Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology settingTuffaha, Haitham (2005). Implementation and validation of a method for characterising prescribing activity and associated pharmaceutical activity in haematology setting. M.Sc Thesis, School of Pharmacy, University of Strathclyde. |
